Scinai Immunotherapeutics
SCNI
11 hedge funds and large institutions have $4.43M invested in Scinai Immunotherapeutics in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
84% more capital invested
Capital invested by funds: $2.41M → $4.43M (+$2.02M)
38% more funds holding
Funds holding: 8 → 11 (+3)
0% more ownership
Funds ownership: 0% → 0% (+0%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mariner
Overland Park,
Kansas
|
+$348K |
| 2 |
Renaissance Technologies
New York
|
+$87.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.84K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
II
1
Ibex Investors
Denver,
Colorado
| $3.33M | – | – | – |
|
|
2
Mariner
Overland Park,
Kansas
| $525K | +$348K | +566 | New |
|
|
BHB
3
Bank Hapoalim BM
Tel Aviv,
Israel
| $232K | – | – | – |
|
4
HighTower Advisors
Chicago,
Illinois
| $157K | – | – | – |
|
|
5
Renaissance Technologies
New York
| $133K | +$87.8K | +143 | New |
|
|
LTFS
6
Ladenburg Thalmann Financial Services
Miami,
Florida
| $23K | – | – | – |
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| $8K | – | – | – |
|
8
Wells Fargo
San Francisco,
California
| $8K | – | – | – |
|
9
Morgan Stanley
New York
| $6K | – | – | – |
|
|
RWB
10
RMR Wealth Builders
Montclair,
New Jersey
| $2K | +$1.23K | +2 | New |
|
|
11
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1K | -$1.84K | -3 | -60% |
|
SCNI Hedge Fund Activity: Q4 2019 in Review
11 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Scinai Immunotherapeutics (SCNI) for Q4 2019, worth a combined $4.43M — up 84% from $2.41M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new SCNI positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Mariner, opening a new position worth an estimated $348K. The largest seller was Deutsche Bank, cutting an estimated $1.84K.
- 11 institutional investors held Scinai Immunotherapeutics (SCNI) as of Q4 2019, up from 8 in Q3 2019.
- Funds reported $4.43M of Scinai Immunotherapeutics stock for Q4 2019, up 84% quarter-over-quarter.
- 3 funds opened new Scinai Immunotherapeutics positions in Q4 2019 and 0 closed out, a net change of +3 holders.
- The largest Scinai Immunotherapeutics buyer in Q4 2019 was Mariner, an estimated $348K added.
- The largest Scinai Immunotherapeutics seller in Q4 2019 was Deutsche Bank, an estimated $1.84K sold.
Based on aggregated 13F filings for Q4 2019.